Or listen here on Apple Podcasts.
In this episode, host and Paradromics CEO, Matt Angle, speaks with fellow Neurotech CEOs, Konstantinos Alataris, Frank Fischer, and Marcus Gerhardt.
“We cover a lot in this discussion, but one of the big themes is how challenging it can be to raise money, to build neuro devices. This episode was originally recorded last winter, and it was instantly one of my favorite episodes. So like a fine wine, I laid it down until the time was right to share it with friends. Since the episode was recorded, Nesos, Paradromics, and BlackRock all had major funding announcements. Nesos and BlackRock underwent rebranding campaigns, and NeuroPace went public on Nasdaq. This podcast was recorded during a bleak winter, but our optimism proved prescient. The podcast aged well, and now the field is the strongest, best funded, and most exciting that it’s ever been. I know you’ll enjoy the discussion.”
Matt Angle, CEO, Paradromics
Show Notes:
1:08 | Meeting Heros
2:18 | The Ian Burkhart Foundation
5:55 | Vasilis Marmarelis, PhD
7:35 | BCI All-Stars
7:48 | Winfried Denk, PhD
8:02 | Company Origins: NeuroPace, Blackrock, and Nēsos
8:48 | NeuroPace
9:08 | Ventritex
9:36 | Robert Fischell, PhD
9:58 | Meet the Fischell’s
10:11 | Irving S. Cooper, MD
13:04 | Epilepsy Monitoring Unit at Columbia
14:01 | The Utah Array
14:21 | Richard A. Normann, MD, PhD
15:05 | John Donoghue, PhD
17:07 | Cyberkinetics
16:28 | Kleiner Perkins
20:05 | Letos
20:09 | Cyberonics
20:13 | Northstar Neuroscience
21:09 | Nevro
22:53 | Effect of High-Frequency Stimulation on Pain Transmission
23:24 | Jason M. Cuellar, MD, PhD
25:28 | Now vs Then, a Decade of Neurotech Entrepreneurship
25:29 | Nēsos (formally Vorso Corp)
26:26 | Inspire Sleep Apnea Implant
26:55 | Neuroimmune Interactions
27:01 | Wearable Nervous Stimulation Technology
27:11 | Landmark Clinical Trial
28:40 | Florian Solzbacher, PhD
32:52 | Cochlear Implant
43:47 | Epilepsy Seizures Recording
47:41 | Argus II Retinal Implant
51:03 | Jennifer Collinger, PhD
51:14 | Nathan Copeland
54:31 | Medicare Coverage of Innovative Technology
54:44 | Synchron’s Breakthrough Device Designation
57:12 | Robert Greenberg, MD
57:16 | Alfred Mann Foundation
1:00:15 | Natus Neuro
1:04:50 | Investor Backing in Neurotech
1:10:55 | Brian Johnson’s Kernel
1:13:24 | Moderna Therapeutics
1:20:44 | BCI Future Is Underway
1:24:30 | RNS therapy for addictive behaviors
1:24:44 | Preclinical Research on Addictive Behavior
1:27:20 | Huma
Want More?
Share Podcast
